+86 16650237703
Author:Kangdi 28-07-2026
Audience: Importers, distributors, and private-label brand owners evaluating Chinese pain patch OEM manufacturers.
Reading time: 16 minutes
What you'll get: A practical database of 10 China-based pain patch OEM manufacturers with MOQ, lead time, FOB pricing, and key certifications. Includes a screening framework, red-flag indicators, and 6 buyer FAQ.
1. Why 2026 Demands a Rigorous Pain Patch OEM Shortlist
Pain patch sourcing from China in 2026 is structurally different from 2020. Hundreds of new factories entered the market between 2022-2025, and a single factory search on Made-in-China or Alibaba returns 300+ suppliers with vastly different capabilities, certifications, and reliability. For B2B buyers, the challenge is not finding suppliers — it is finding the right suppliers.
Most importers waste 4-6 months and $15,000-50,000 in qualification costs talking to the wrong factories. A structured shortlist cuts this to 2-3 months and $5,000-15,000 by focusing evaluation resources on the most capable manufacturers.
The 10-factory database below is curated for serious B2B buyers. Each factory is independently operated (not a trading company), has at least 5 years of pain patch manufacturing history, and exports to regulated markets (US, EU, or GCC). MOQ, lead time, and pricing are derived from public sources and buyer reports; verify with the factory directly before making sourcing decisions.
For regulatory context, see our companion guide on Pain Relief Patch OEM Compliance 2026: FDA vs EU MDR vs GCC vs NMPA and Pain Patch OEM Factory Audit 2026 (Part 2).
2. The 10-Factory Database (2026 Edition)
| # | Manufacturer | Location | Established | Capacity (patches/mo) | MOQ | Lead Time | FOB Price Range (USD/patch) | Key Certifications |
|---|---|---|---|---|---|---|---|---|
| 1 | Henan Kangdi Medical Devices Co., Ltd. | Henan | 1989 | 5,000,000+ | 50,000 | 25-35 days | $0.08-0.35 | ISO 13485, ISO 22716, FDA registration, EU CPNP, GCC SFDA |
| 2 | Guangzhou Battle-Win Biotech | Guangdong | 2005 | 3,000,000 | 100,000 | 30-45 days | $0.10-0.40 | ISO 13485, CE mark, FDA establishment registration |
| 3 | Wuhan Huawei Technology | Hubei | 2008 | 2,500,000 | 50,000 | 20-30 days | $0.12-0.45 | ISO 13485, NMPA, EU CPNP |
| 4 | Shanghai Shoutai Pharmaceutical | Shanghai | 2010 | 2,000,000 | 100,000 | 30-40 days | $0.15-0.50 | 21 CFR 210/211 GMP, ISO 13485, FDA registration |
| 5 | Shijiazhuang Yiling Pharmaceutical | Hebei | 1998 | 4,000,000 | 80,000 | 30-50 days | $0.10-0.40 | ISO 13485, NMPA Class II, EU CPNP |
| 6 | Hangzhou Chuangyi Biotech | Zhejiang | 2012 | 1,500,000 | 50,000 | 25-35 days | $0.12-0.42 | ISO 22716, ISO 13485, FDA establishment registration |
| 7 | Shenzhen TMok Healthcare | Guangdong | 2014 | 1,800,000 | 60,000 | 20-30 days | $0.10-0.38 | ISO 13485, CE mark, GCC SFDA |
| 8 | Zhengzhou Linuo Biological | Henan | 2011 | 2,200,000 | 50,000 | 25-40 days | $0.08-0.32 | ISO 13485, NMPA, FDA registration |
| 9 | Jiangsu Yuyue Medical Equipment | Jiangsu | 2002 | 3,500,000 | 100,000 | 30-45 days | $0.12-0.45 | ISO 13485, 21 CFR 210/211 GMP, EU CE mark, FDA registration |
| 10 | Chengdu Xinhui Biotech | Sichuan | 2015 | 1,200,000 | 40,000 | 20-30 days | $0.10-0.36 | ISO 22716, NMPA, EU CPNP |
Note: Pricing varies by patch type, API content, and packaging complexity. Capsaicin and lidocaine patches are at the upper end; menthol and herbal patches at the lower end. Volume discounts typically apply at 500,000+ patches per SKU.
3. Manufacturer Profiles (What Each Factory Specializes In)
3.1 Henan Kangdi Medical Devices Co., Ltd. (Founded 1989)
The longest-operating factory on this list. Kangdi's strength is breadth: warming patches, menthol cooling patches, herbal pain patches, capsicum plasters, fever patches, and hydrogel patches all under one roof. Capacity of 5M+ patches/month is the highest among the listed manufacturers.
- Best for: B2B buyers needing a single supplier for multiple product categories
- Export markets: US, EU, GCC, Japan, Southeast Asia
- Key differentiator: 35+ years of patch manufacturing; full documentation package; accepts low-MOQ pilot orders
3.2 Guangzhou Battle-Win Biotech (Founded 2005)
Mid-size Guangdong manufacturer focused on capsaicin and menthol patches. Strong in-house R&D team and bilingual sales coverage. CE mark + FDA establishment registration makes it a viable option for US and EU importers.
- Best for: Capsaicin / menthol patch specialists
- Export markets: US, EU, Southeast Asia
- Key differentiator: R&D customization (formulation + packaging)
3.3 Wuhan Huawei Technology (Founded 2008)
Specializes in capsaicin plasters and warming patches. Hubei-based with NMPA Class II medical device registration. Solid CPNP coverage for EU importers but limited US footprint.
- Best for: EU-focused capsicum plaster sourcing
- Export markets: EU, Southeast Asia, Middle East
- Key differentiator: NMPA Class II registration enables 国械注准 positioning
3.4 Shanghai Shoutai Pharmaceutical (Founded 2010)
One of the few manufacturers on this list with 21 CFR 210/211 GMP compliance. Higher price points reflect the GMP overhead. Best for buyers targeting US OTC positioning.
- Best for: US OTC positioning (lidocaine, capsaicin, menthol)
- Export markets: US, EU
- Key differentiator: 21 CFR 210/211 GMP certification
3.5 Shijiazhuang Yiling Pharmaceutical (Founded 1998)
A traditional Chinese medicine (TCM) company that has expanded into topical pain patches. Strong in herbal API sourcing. NMPA Class II registration covers capsaicin and menthol products.
- Best for: TCM / herbal pain patch positioning
- Export markets: EU, GCC, Southeast Asia, domestic China
- Key differentiator: Vertical integration with herbal API sources
3.6 Hangzhou Chuangyi Biotech (Founded 2012)
Cosmetic-positioned manufacturer focused on menthol and arnica patches. ISO 22716 cosmetic GMP + ISO 13485 medical device coverage provides flexibility for both cosmetic and medical positioning.
- Best for: Cosmetic / cosmetic-with-structure-function claims positioning
- Export markets: US, EU, GCC
- Key differentiator: Dual ISO 13485 + ISO 22716 certification
3.7 Shenzhen TMok Healthcare (Founded 2014)
Younger Guangdong manufacturer with strong R&D investment. CE mark + GCC SFDA coverage is well-suited for European and Middle Eastern buyers. Pricing competitive at 1.8M capacity.
- Best for: Mid-volume EU + GCC sourcing
- Export markets: EU, GCC, Southeast Asia
- Key differentiator: Strong English-speaking sales team, fast sample turnaround
3.8 Zhengzhou Linuo Biological (Founded 2011)
Henan-based manufacturer specializing in hydrogel patches and fever patches. NMPA + FDA establishment registration supports both US cosmetic and Chinese domestic positioning.
- Best for: Hydrogel / fever patch sourcing
- Export markets: US, China, Southeast Asia
- Key differentiator: Hydrogel technology expertise
3.9 Jiangsu Yuyue Medical Equipment (Founded 2002)
Publicly listed medical device manufacturer with strong regulatory credentials. Higher MOQ (100,000) but more rigorous quality system. 21 CFR 210/211 GMP + ISO 13485 + CE mark + FDA registration — best-in-class documentation.
- Best for: High-volume buyers needing rigorous documentation
- Export markets: US, EU, GCC, Japan, domestic China
- Key differentiator: Public company financial transparency; comprehensive certification coverage
3.10 Chengdu Xinhui Biotech (Founded 2015)
Younger Sichuan-based manufacturer with the lowest MOQ (40,000) on this list. ISO 22716 cosmetic GMP + NMPA + EU CPNP coverage. Best for buyers piloting new product lines.
- Best for: First-time buyers piloting new product lines
- Export markets: EU, Southeast Asia, domestic China
- Key differentiator: Lowest MOQ + flexible first-PO terms
4. How to Use This Database: 3-Stage Selection Framework
Stage 1: Filter by Market (15 → 5-7 candidates)
Start with target market requirements:
- US importers: filter to factories with FDA establishment registration — eliminates Huawei, Yiling, Xinhui, Chuangyi may need verification
- EU importers: filter to factories with CPNP / CE mark / ISO 13485 — all 10 qualify but verify scope
- GCC importers: filter to factories with GCC SFDA / GSO conformity — Kangdi, Battle-Win, TMok, Yuyue verified
- Multi-market importers: Kangdi, Yuyue, Yiling have widest coverage
Stage 2: Filter by Product Category (5-7 → 3-4 candidates)
Match factory specialization to product category:
- Capsaicin plasters: Kangdi, Battle-Win, Huawei, Yiling, Yuyue
- Menthol cooling: Kangdi, Battle-Win, Chuangyi, Yuyue
- Lidocaine / 21 CFR 210/211 positioning: Shoutai, Yuyue, Kangdi
- Fever patches (pediatric): Kangdi, Linuo
- Hydrogel patches: Linuo, Kangdi
- Herbal / TCM: Yiling, Kangdi
Stage 3: Shortlist 2-3 Factories for Sample Testing
From the filtered list, narrow to 2-3 finalists based on:
- MOQ flexibility (especially for first PO)
- Lead time alignment with your launch timeline
- FOB pricing competitiveness for your target margin
- Quality system maturity (request audit reports)
- Communication / English capability
For the full qualification process after shortlisting, see Pain Patch OEM Factory Audit 2026 (Part 1).
5. Red Flags to Watch for in This Database
Even with a curated list, verify before committing:
- Capacity claims: any factory claiming >3M patches/month should be verified with production line walkthrough
- Lead time: <20 days for first PO is suspicious — first PO typically requires material procurement + scheduling + QC
- MOQ claims: MOQ <30,000 for first PO may indicate trading company, not factory
- FOB price: below $0.08/patch for warming patch is suspicious — likely sub-standard adhesive or low-grade materials
- Certifications: verify each certificate with the issuing body (IAF MLA accreditation check)
- Year founded: post-2020 factories carry higher risk; allow extra qualification time
6. Pricing Benchmarks by Patch Type (2026 Market)
| Patch Type | Typical FOB Range (USD/patch) | Main Cost Drivers |
|---|---|---|
| Warming / heat patch (iron powder based) | $0.08-0.20 | Patch size, packaging, iron powder grade |
| Menthol cooling patch | $0.10-0.25 | Menthol concentration, hydrogel substrate, packaging |
| Capsaicin plaster | $0.15-0.40 | Capsaicin grade, plaster matrix, occlusive backing |
| Lidocaine patch | $0.30-0.80 | Lidocaine API cost, monograph positioning, 21 CFR 210/211 GMP overhead |
| Hydrogel patch (fever / cooling) | $0.10-0.30 | Hydrogel thickness, backing film, packaging |
| Herbal / TCM pain patch | $0.12-0.35 | Herbal extract grade, formulation complexity |
| Arnica pain patch | $0.15-0.40 | Arnica extract grade, organic certification overhead |
Volume discount: typically 8-15% at 500,000 patches; 12-22% at 1,000,000+ patches per SKU. Cosmetic-positioned patches are 30-50% cheaper than monograph-positioned equivalents due to GMP overhead.
7. Lead Time Benchmarks by Order Type
| Order Type | Typical Lead Time | Notes |
|---|---|---|
| Stock SKU (generic catalog product) | 7-15 days | No formulation / packaging change |
| Custom formulation | 30-50 days | Includes R&D, sample approval, batch records |
| Custom packaging (artwork only) | 20-35 days | Artwork design + first production run |
| First PO (with pilot run) | 40-75 days | Includes sample testing, contract negotiation, payment |
| Repeat PO (post first delivery) | 25-45 days | Faster with established quality agreement |
8. FAQ (6 Questions)
FAQ 1: How do I verify a factory's claim of "FDA registered"?
Search the FDA DRLS (Facility Registration and Listing System) database at https://www.accessdata.fda.gov/scripts/oombu/ using the factory's FEI number. A "registered" factory will appear with active registration status. If the factory cannot provide an FEI number, treat the claim as unverified.
Note that FDA registration only means the factory has filed the registration — it does not mean the products are cleared, approved, or 21 CFR 210/211 positioning. Verify separately that the product is positioned correctly for the intended market (cosmetic, OTC, or other).
FAQ 2: Is the cheapest factory always the best choice?
No. In 2024-2025, B2B buyers who selected factories based purely on FOB price reported the highest defect rates (3-8%) and the most regulatory enforcement actions. Low-priced factories typically cut corners on adhesive quality, API grade, packaging, or quality system documentation.
For B2B positioning where brand reputation matters, the total cost of ownership (TCO) — including defect replacement, regulatory risk, and customer complaints — is typically 20-40% lower with a mid-priced factory than a low-priced factory.
FAQ 3: Can I work with multiple factories on the list simultaneously?
Yes — and it is recommended for buyers with multiple product lines. Many serious B2B buyers split sourcing across 2-3 factories: e.g. Kangdi for warming patches, Yuyue for lidocaine, Xinhui for low-MOQ piloting. This diversification reduces single-factory risk and gives you negotiation leverage.
However, for first-time importers, focus on one factory initially to keep qualification complexity manageable. Add second / third factories after 6-12 months of stable supply from the first.
FAQ 4: What if my preferred factory is not on this list?
The 10 factories listed are the most capable, but there are 50+ additional qualified pain patch OEM manufacturers in China. If you have a candidate not on this list, evaluate it against the same criteria: years in business, independent factory (not trading company), certifications, capacity, export markets, and buyer references.
Use this list as a baseline, not an exclusive shortlist. A factory with strong English sales reps, transparent documentation, and verifiable audit history may be a better fit than a less-engaged factory from the top 10.
FAQ 5: How often is this database updated?
The database is reviewed annually. For 2026, the list reflects manufacturer status as of Q1 2026. Factory details (capacity, certifications, contact) change frequently — verify directly with each factory before initiating qualification.
For B2B buyers who need a more frequently updated list or who want pre-screened factories matched to their specific product category, contact our sourcing team at kangdimedical@gmail.com for a curated shortlist.
FAQ 6: What is the typical first-PO investment for a serious buyer?
Total first-PO investment for a rigorous buyer (assuming cosmetic positioning):
- Sample testing: $3,000-8,000 (1-2 factories × third-party test panel)
- Factory audit: $3,000-5,000 (third-party audit firm) or $5,000-8,000 (in-person)
- First PO value: $5,000-15,000 (50,000 patches × $0.10-0.30 FOB)
- Regulatory readiness: $2,000-5,000 (CPNP / FDA registration / NMPA filing)
- Travel and overhead: $2,000-5,000
Total first-PO investment: $15,000-40,000 for cosmetic positioning; $50,000-150,000 for 21 CFR 210/211 / MDR positioning. For buyers with budget under $10,000, focus on cosmetic-only positioning and skip on-site audit (use third-party audit firm).
9. Conclusion
The 10-factory database above is a starting point for rigorous B2B sourcing of pain patch OEM manufacturers in China. Each manufacturer offers distinct strengths: Kangdi for breadth, Yuyue for compliance rigor, Shoutai for OTC positioning, Xinhui for low-MOQ piloting. Use the 3-stage selection framework to filter by market, product category, and shortlist criteria, then move to the full qualification process with 2-3 finalists.
For most B2B buyers evaluating pain patch OEMs in 2026, a 2-3 month structured qualification with one of the factories on this list — supplemented with on-site audit, third-party lab testing, and rigorous quality agreement — yields reliable, repeatable supply for $0.08-0.40/patch FOB depending on product category and positioning.
If you would like to discuss pain patch OEM sourcing with our team, including formulation capabilities, sample requests, and audit history, contact Henan Kangdi Medical Devices at kangdimedical@gmail.com or +86 155 1754 1011. We have produced warming patches, menthol cooling patches, herbal pain patches, and capsicum plasters since 1989, and we welcome serious B2B buyers for OEM/ODM partnerships with full regulatory documentation support.
References
- FDA Facility Registration (DRLS): https://www.accessdata.fda.gov/scripts/oombu/
- EU CPNP Cosmetic Product Notification Portal: https://ec.europa.eu/growth/sectors/cosmetics/cpnp/
- EU NANDO Notified Bodies database: https://ec.europa.eu/growth/tools-databases/nando/
- EU MDR 2017/745: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32017R0745
- EU Cosmetics Regulation 1223/2009: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32009R1223
- ISO 13485 — Medical Devices QMS: https://www.iso.org/standard/59752.html
- ISO 22716 — Cosmetic GMP: https://www.iso.org/standard/36494.html
- 21 CFR 210/211 — GMP for Finished Pharmaceuticals: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-210
- NMPA — National Medical Products Administration: https://www.nmpa.gov.cn/
- GCC SFDA — Saudi Food and Drug Authority: https://www.sfda.gov.sa/
- Made-in-China: https://www.made-in-china.com
- Alibaba International: https://www.alibaba.com
- GlobalSources: https://www.globalsources.com
- Thomasnet: https://www.thomasnet.com
- CMEF (China International Medical Equipment Fair): https://www.cmef.com.cn/
Contact: For OEM/ODM inquiries, email kangdimedical@gmail.com or call +86 155 1754 1011.Updated: July 2026. Information current as of publication date; factory details, certifications, and pricing change frequently. Always verify directly with the manufacturer before making sourcing decisions.